Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape
Gut and Liver · 15.09.2025 · 19 (5) · 633-634
DOI: 10.5009/gnl250399 ↗Kurz gefasst
Editorial in der Zeitschrift Gut and Liver, erschienen am 15.09.2025. Verfasst von Dong Chan Joo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
ORCID-Profile: Dong Chan Joo, Gwang Ha Kim
Zitieren
APA
Joo, D. C., & Kim, G. H. (2025). Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape. Gut and Liver, 19(5), 633-634. https://doi.org/10.5009/gnl250399
Vancouver
Joo DC, Kim GH. Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape. Gut and Liver. 2025;19(5):633-634. doi:10.5009/gnl250399
BibTeX
@article{Joo2025,
author = {Joo, Dong Chan and Kim, Gwang Ha},
title = {Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape},
journal = {Gut and Liver},
year = {2025},
volume = {19},
number = {5},
pages = {633--634},
doi = {10.5009/gnl250399}
}
EUVIMED